O1.05 AXITINIB, A SELECTIVE VEGFR-1,-2,-3 TYROSINE KINASE INHIBITOR, INHIBITS TUMOR GROWTH AND INCREASES INFILTRATION OF IMMUNE CELLS IN AN INTRACRANIAL MELANOMA MOUSE MODEL

VEGF is a key mediator of pathological cancer associated neoangiogenesis and immunosuppression. VEGFR targeted therapy holds promise to counteract cancer associated neoangiogenesis but also to alleviate cancer associated immune suppression. Melanoma patients are at high risk for developing brain met...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Du Four, S., Maenhout, S.K., Niclou, S.P., Thielemans, K., Neyns, B., Aerts, J.L.
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2014
Assuntos:
ORAL PRESENTATIONS
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4185817/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou174.5
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados